440 related articles for article (PubMed ID: 30778623)
1. Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis.
Teng X; Ji C; Zhong H; Zheng D; Ni R; Hill DJ; Xiong S; Fan GC; Greer PA; Shen Z; Peng T
Diabetologia; 2019 May; 62(5):860-872. PubMed ID: 30778623
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes.
Li Y; Ma J; Zhu H; Singh M; Hill D; Greer PA; Arnold JM; Abel ED; Peng T
Diabetes; 2011 Nov; 60(11):2985-94. PubMed ID: 21911754
[TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
Liu P; Su J; Song X; Wang S
Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
[TBL] [Abstract][Full Text] [Related]
5. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
[TBL] [Abstract][Full Text] [Related]
6. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
[TBL] [Abstract][Full Text] [Related]
7. Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress.
Li S; Zhang L; Ni R; Cao T; Zheng D; Xiong S; Greer PA; Fan GC; Peng T
Biochim Biophys Acta; 2016 Nov; 1862(11):2023-2033. PubMed ID: 27523632
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy.
Ni R; Zheng D; Xiong S; Hill DJ; Sun T; Gardiner RB; Fan GC; Lu Y; Abel ED; Greer PA; Peng T
Diabetes; 2016 Jan; 65(1):255-68. PubMed ID: 26470784
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Capn4 gene inhibits nuclear factor-κB (NF-κB) protein signaling/inflammation and reduces remodeling after myocardial infarction.
Ma J; Wei M; Wang Q; Li J; Wang H; Liu W; Lacefield JC; Greer PA; Karmazyn M; Fan GC; Peng T
J Biol Chem; 2012 Aug; 287(33):27480-9. PubMed ID: 22753411
[TBL] [Abstract][Full Text] [Related]
10. Calpain activation mediates microgravity-induced myocardial abnormalities in mice via p38 and ERK1/2 MAPK pathways.
Liang L; Li H; Cao T; Qu L; Zhang L; Fan GC; Greer PA; Li J; Jones DL; Peng T
J Biol Chem; 2020 Dec; 295(49):16840-16851. PubMed ID: 32989050
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
12. Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.
Huang X; Zhang KJ; Jiang JJ; Jiang SY; Lin JB; Lou YJ
Front Endocrinol (Lausanne); 2022; 13():801260. PubMed ID: 35242109
[TBL] [Abstract][Full Text] [Related]
13. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.
Gogiraju R; Xu X; Bochenek ML; Steinbrecher JH; Lehnart SE; Wenzel P; Kessel M; Zeisberg EM; Dobbelstein M; Schäfer K
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713289
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
15. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
16. Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
Chen X; Li Y; Yuan X; Yuan W; Li C; Zeng Y; Lian Y; Qiu X; Qin Y; Zhang G; Liu X; Luo C; Luo JD; Hou N
Diabetes; 2022 Apr; 71(4):795-811. PubMed ID: 35043173
[TBL] [Abstract][Full Text] [Related]
17. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
18. Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.
Zeng H; He X; Hou X; Li L; Chen JX
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H585-97. PubMed ID: 24363305
[TBL] [Abstract][Full Text] [Related]
19. The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes.
Liu D; Xing R; Zhang Q; Tian X; Qi Y; Song H; Liu Y; Yu H; Zhang X; Jing Q; Yan C; Han Y
Exp Mol Med; 2023 Sep; 55(9):2025-2038. PubMed ID: 37658156
[TBL] [Abstract][Full Text] [Related]
20. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
